Anthrax infection in drug users

The Lancet

Volumn 375, Issue 9723, 2010, Pages 1345-1346

  Booth, Malcolm G ^a   Hood, John ^a   Brooks, Timothy JG ^b   Hart, Andrew ^a,c,d  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c UMEÅ UNIVERSITY   (Sweden)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; NORADRENALIN; VASOPRESSIN;

ANTHRAX; ARTIFICIAL VENTILATION; ASCITES; BACILLUS ANTHRACIS; BACTERIUM CULTURE; BLEEDING; BLOOD CLOTTING DISORDER; CLINICAL ASSESSMENT; CLINICAL FEATURE; DEBRIDEMENT; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DRUG USE; GASTROINTESTINAL INFECTION; GASTROINTESTINAL SYMPTOM; GRAM STAINING; HEROIN DEPENDENCE; HIGH RISK POPULATION; HUMAN; INJECTION SITE INFECTION; LETTER; MORTALITY; NECROSIS; PLEURA EFFUSION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT; SEPTIC SHOCK; SKIN INFECTION; SKIN MANIFESTATION; SOFT TISSUE INFECTION; SUBCUTANEOUS FAT; TACHYCARDIA; THROMBOCYTOPENIA; UNITED KINGDOM;

EID: 77950806358     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)60573-9     Document Type: Letter

References (2)

1. Ringertz S.H., Hoiby E.A., Jesenius M., et al. Injectional anthrax in a heroin skin-popper. Lancet 356 (2000) 1574-1575
2. Health Protection Scotland. Interim clinical guidelines for the management of suspected anthrax in drug users: version 12.1. http://www.hps.scot.nhs.uk/anthrax/documents/clinical-guidance-for-use-of-anthrax-immune-globulin-v12-1-2010-03-19.pdf (accessed March 31, 2010).